Reported about 1 year ago
On June 28, 2024, the Japanese Health Ministry announced a total of 76 new suspected deaths related to the consumption of Kobayashi Pharmaceutical's red yeast rice health products. Due to perceived lack of transparency from Kobayashi Pharmaceutical, the Health Ministry will take over the management of the situation. As of June 26, the incident has resulted in 5 deaths, 289 hospitalizations, and 1,656 individuals seeking medical treatment, with an additional 170 suspected death cases reported. However, 94 cases were confirmed not related to the product, while the remaining 76 are still unconfirmed. The Ministry expressed frustration at Kobayashi Pharmaceutical's failure to report relevant health damage information as requested, leading to their decision to take control of the management going forward.
Source: YAHOO